Osteora
Osteora
Explore our precision-engineered surgical kits and trauma stabilization implants manufactured under stringent international standards.
Navigating the complex ecosystem of orthopedic biomaterials through rigorous research, clinical validation, and global regulatory compliance.
The worldwide demand for high-viscosity and low-viscosity bone cements continues to escalate due to an aging global demographic and the rising prevalence of osteoporosis-related vertebral compression fractures and joint degeneration. As a premier hub for medical manufacturing, China has transformed into a reliable powerhouse providing cost-effective yet internationally compliant polymethylmethacrylate (PMMA) bone cement formulas and delivery systems.
Advanced bone cements require precise control over setting time, exothermic reaction temperature, compressive strength, and radiopacity. Top-tier Chinese manufacturers utilize automated vacuum mixing systems and high-purity barium sulfate additives to eliminate porosity, ensuring optimal mechanical interlocking between the implant interface and host trabecular bone during vertebroplasty, kyphoplasty, and arthroplasty procedures.
Mitigating polymerization risks and monomer toxicity remains paramount. Modern bone cement delivery kits feature specialized cement injectors, mixing bowls, and pressure-control mechanisms designed to minimize fat embolism and thermal necrosis, aligning completely with strict clinical expectations across international surgical centers.
Uncompromising dedication to quality assurance, advanced research and development, and global medical device distribution.
Osteora Medical Devices Co., Ltd. is a professional orthopedic implant and surgical solution manufacturer specializing in trauma, spine, and joint reconstruction systems under the brand Osteora. Founded in 2016, the company operates within an extensive facility covering approximately 18,500㎡, supporting integrated production, assembly, and testing operations.
With 8 years of export experience and 12 years of industry expertise, Osteora maintains robust partnerships with global distributors and healthcare institutions. Annual export revenue consistently ranges from USD 6 million to 14 million, driven by an agile supply chain comprising over 1,200 certified upstream and downstream partners.
An in-house engineering team of 85 R&D engineers spearheads continuous innovation in trauma fixation, spinal implants, and joint reconstruction technologies. In the past year alone, Osteora launched approximately 120 new products, ensuring clinicians worldwide have access to state-of-the-art medical solutions.
Rigorous multi-stage inspection protocols ensuring zero-defect delivery for critical life-supporting surgical implants.
The company implements comprehensive quality assurance systems, including ISO 13485 compliance, in-process inspection, and final random sampling testing. Product inspection methodologies incorporate dimensional measurement, mechanical fatigue testing, and biocompatibility validation executed by a specialized team of 42 quality inspectors.
Osteora maintains an established trade background with primary export destinations spanning Europe, Southeast Asia, the Middle East, and South America. We provide extensive customization services, including OEM/ODM services, tailored dimensional variations, material customization, and private labeling to satisfy distinct regional regulatory frameworks.
A visual walkthrough of our state-of-the-art production floors, advanced CNC machinery, and metrology testing laboratories.
Discover our comprehensive range of specialized orthopedic implants, bone cement mixers, and veterinary surgical instrumentation.
Expert answers regarding our bone cement manufacturing, OEM/ODM services, and international distribution standards.
